查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386204

儿童用疫苗市场报告：2030 年趋势、预测与竞争分析

Pediatric Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

儿童用疫苗趋势和预测

预计到 2030 年，全球儿童用疫苗市场将达到 308 亿美元，2024 年至 2030 年复合年增长率为 5.7%。该市场的主要驱动力是家长和医疗保健相关人员对这些疫苗益处的认识不断提高、对组合疫苗的需求不断增长以及新型创新儿童用疫苗的出现。这是一个持续发展的过程。全球儿童用疫苗市场的未来充满希望，在感染疾病、癌症、过敏、肺炎球菌疾病以及流感、麻疹、腮腺炎和德国德国麻疹（MMR）应用方面存在机会。

儿童用疫苗市场洞察

Lucintel 预测，由于大量使用结合形式来抑制这些病毒，肺炎球菌和脑膜炎球菌疾病将在预测期内出现最高增长。

由于拥有强大的医疗基础设施、政府在免疫计划方面的积极配合措施以及不断增长的儿童人口，预计北美在预测期内将出现最高的增长。

市场规模/估计：以金额的儿童用疫苗市场规模估计（十亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按疫苗类型、技术、应用和地区分類的儿童用疫苗市场规模（金额（$B））。

区域分析：北美、欧洲、亚太地区和世界其他地区的儿童用疫苗市场细分。

成长机会：按类型、技术、应用和地区分析儿童用疫苗的成长机会。

策略分析：儿童用疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球儿童用疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球儿童用疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按疫苗类型分類的全球儿童用疫苗市场
    • 单价
    • 多效价的
  • 按技术分類的全球儿童用疫苗市场
    • 减弱毒性
    • 失活
    • 次单元
    • 类毒素
    • 共轭
    • 其他的
  • 全球儿童用疫苗市场（按应用）
    • 感染疾病
    • 癌症
    • 过敏
    • 肺炎球菌疾病
    • 流感
    • 麻疹、腮腺炎、德国麻疹(MMR)
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球儿童用疫苗市场区域分布
  • 北美儿童用疫苗市场
  • 欧洲儿童用疫苗市场
  • 亚太地区儿童用疫苗市场
  • 其他地区儿童用疫苗市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按疫苗类型分類的全球儿童用疫苗市场成长机会
    • 全球儿童用疫苗市场成长机会（按技术）
    • 全球儿童用疫苗市场成长机会（按应用）
    • 全球儿童用疫苗市场成长机会（按地区）
  • 全球儿童用疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球儿童用疫苗市场产能扩张
    • 全球儿童用疫苗市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • GlaxoSmithKline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute of India
简介目录

Pediatric Vaccine Trends and Forecast

The future of the global pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications. The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

A more than 150-page report is developed to help in your business decisions.

Pediatric Vaccine by Segment

The study includes a forecast for the global pediatric vaccine by vaccine type, technology, application, and region.

Pediatric Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent
  • Multivalent

Pediatric Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Live Attenuated
  • Inactivated
  • Subunit
  • Toxoid
  • Conjugate
  • Others

Pediatric Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Infectious Disease
  • Cancer
  • Allergy
  • Pneumococcal Disease
  • Influenza
  • Measles, Mumps, and Rubella (Mmr)
  • Others

Pediatric Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pediatric Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pediatric vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pediatric vaccine companies profiled in this report include-

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute Of India

Pediatric Vaccine Market Insights

Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Features of the Global Pediatric Vaccine Market

Market Size Estimates: Pediatric vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pediatric vaccine market size by vaccine type, technology, application, and region in terms of value ($B).

Regional Analysis: Pediatric vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, applications, and regions for the pediatric vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pediatric vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pediatric vaccine market size?

Answer: The global pediatric vaccine market is expected to reach an estimated $30.8 billion by 2030.

Q.2 What is the growth forecast for pediatric vaccine market?

Answer: The global pediatric vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pediatric vaccine market?

Answer: The major drivers for this market are rising awareness of the benefits of these vaccines among parents and medical professionals, growing demand for combination vaccines, and continous development of new and innovative pediatric vaccines.

Q4. What are the major segments for pediatric vaccine market?

Answer: The future of the pediatric vaccine market looks promising with opportunities in the infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, and mumps, and rubella (MMR) applications.

Q5. Who are the key pediatric vaccine market companies?

Answer: Some of the key pediatric vaccine companies are as follows:

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Pfizer
  • Johnson & Johnson
  • Bharat Biotech International
  • Serum Institute Of India

Q6. Which pediatric vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that conjugate is expected to witness highest growth over the forecast period due to its significant usage in pneumococcal and meningococcal diseases to provide restraining power against these viruses.

Q7. In pediatric vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of robust healthcare infrastructure, supportive government initiative for immunization programs, and growing of pediatric population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pediatric vaccine market by vaccine type (monovalent and multivalent), technology (live attenuated, inactivated, subunit, toxoid, conjugate, and others), application (infectious disease, cancer, allergy, pneumococcal disease, influenza, measles, mumps, and rubella (MMR), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pediatric Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pediatric Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pediatric Vaccine Market by Vaccine Type
    • 3.3.1: Monovalent
    • 3.3.2: Multivalent
  • 3.4: Global Pediatric Vaccine Market by Technology
    • 3.4.1: Live Attenuated
    • 3.4.2: Inactivated
    • 3.4.3: Subunit
    • 3.4.4: Toxoid
    • 3.4.5: Conjugate
    • 3.4.6: Others
  • 3.5: Global Pediatric Vaccine Market by Application
    • 3.5.1: Infectious Disease
    • 3.5.2: Cancer
    • 3.5.3: Allergy
    • 3.5.4: Pneumococcal Disease
    • 3.5.5: Influenza
    • 3.5.6: Measles, Mumps, and Rubella (MMR)
    • 3.5.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pediatric Vaccine Market by Region
  • 4.2: North American Pediatric Vaccine Market
    • 4.2.1: North American Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.2.2: North American Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.3: European Pediatric Vaccine Market
    • 4.3.1: European Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.3.2: European Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.4: APAC Pediatric Vaccine Market
    • 4.4.1: APAC Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.4.2: APAC Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others
  • 4.5: ROW Pediatric Vaccine Market
    • 4.5.1: ROW Pediatric Vaccine Market by Technology: Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate, and Others
    • 4.5.2: ROW Pediatric Vaccine Market by Application: Infectious Disease, Cancer, Allergy, Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pediatric Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Pediatric Vaccine Market by Technology
    • 6.1.3: Growth Opportunities for the Global Pediatric Vaccine Market by Application
    • 6.1.4: Growth Opportunities for the Global Pediatric Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Pediatric Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pediatric Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pediatric Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Merck & Co
  • 7.3: Sanofi
  • 7.4: Pfizer
  • 7.5: Johnson & Johnson
  • 7.6: Bharat Biotech International
  • 7.7: Serum Institute of India